Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$5.89 - $10.52 $6,479 - $11,572
-1,100 Reduced 3.26%
32,690 $224,000
Q4 2022

Jan 27, 2023

SELL
$5.69 - $10.07 $1,138 - $2,014
-200 Reduced 0.59%
33,790 $268,000
Q3 2022

Oct 28, 2022

SELL
$7.17 - $13.87 $1,175 - $2,274
-164 Reduced 0.48%
33,990 $327,000
Q2 2021

Jul 21, 2021

SELL
$12.95 - $15.41 $180,043 - $214,245
-13,903 Reduced 28.93%
34,154 $472,000
Q1 2021

Apr 22, 2021

SELL
$14.42 - $21.39 $60,520 - $89,773
-4,197 Reduced 8.03%
48,057 $702,000
Q4 2020

Jan 25, 2021

SELL
$16.56 - $18.94 $1,655 - $1,894
-100 Reduced 0.19%
52,254 $908,000
Q3 2020

Nov 06, 2020

BUY
$17.41 - $19.89 $214,247 - $244,766
12,306 Added 30.73%
52,354 $0
Q2 2020

Jul 21, 2020

BUY
$14.43 - $19.16 $577,892 - $767,319
40,048 New
40,048 $715,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $86.3M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.